发布求助
文献互助 智能选刊 最新文献

Drugs of The Future最新文献

筛选
英文 中文
Biomarkers in frontotemporal dementia: a narrative review 额颞叶痴呆的生物标志物:叙述性回顾
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.1.3461266
{"title":"Biomarkers in frontotemporal dementia: a narrative review","authors":"","doi":"10.1358/dof.2023.48.1.3461266","DOIUrl":"https://doi.org/10.1358/dof.2023.48.1.3461266","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spesolimab. Anti-IL-36R monoclonal antibody, Treatment of generalized pustular psoriasis, Treatment of immune-mediated inflammatory diseases Spesolimab。抗il - 36r单克隆抗体，治疗全身性脓疱性银屑病，治疗免疫介导的炎症性疾病
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.3.3500035
V. Nielsen, Y. Yao, A. Egeberg, S. Thomsen
{"title":"Spesolimab. Anti-IL-36R monoclonal antibody, Treatment of generalized pustular psoriasis, Treatment of immune-mediated inflammatory diseases","authors":"V. Nielsen, Y. Yao, A. Egeberg, S. Thomsen","doi":"10.1358/dof.2023.48.3.3500035","DOIUrl":"https://doi.org/10.1358/dof.2023.48.3.3500035","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AACR-NCI-EORTC - 34th International Symposium on Molecular Targets and Cancer Therapeutics. Barcelona - October 26-28, 2022 AACR-NCI-EORTC -第34届分子靶点和癌症治疗国际研讨会。巴塞罗那——2022年10月26日至28日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.1.3521843
{"title":"AACR-NCI-EORTC - 34th International Symposium on Molecular Targets and Cancer Therapeutics. Barcelona - October 26-28, 2022","authors":"","doi":"10.1358/dof.2023.48.1.3521843","DOIUrl":"https://doi.org/10.1358/dof.2023.48.1.3521843","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"116 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDWeek 2022. Washington, D.C. - October 19-23, 2022 IDWeek 2022。华盛顿特区——2022年10月19日至23日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.1.3521795
J. Nguyen
{"title":"IDWeek 2022. Washington, D.C. - October 19-23, 2022","authors":"J. Nguyen","doi":"10.1358/dof.2023.48.1.3521795","DOIUrl":"https://doi.org/10.1358/dof.2023.48.1.3521795","url":null,"abstract":"IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS) and the Society of Infectious Diseases Pharmacists (SIDP). For the first time since the COVID-19 public health emergency began, IDWeek 2022 returned to in-person attendance. It was held in Washington, D.C., and the meeting comprised 5 days of live sessions and on-demand content that included posters and oral presentations.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Society of Nephrology's (ASN) Kidney Week - 2022 Annual Meeting. Orlando - November 3-6, 2022 美国肾脏病学会(ASN)肾脏周- 2022年年会。奥兰多——2022年11月3日至6日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.1.3521845
{"title":"American Society of Nephrology's (ASN) Kidney Week - 2022 Annual Meeting. Orlando - November 3-6, 2022","authors":"","doi":"10.1358/dof.2023.48.1.3521845","DOIUrl":"https://doi.org/10.1358/dof.2023.48.1.3521845","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma Bimiralisib。磷脂酰肌醇3-激酶(PI3K)/雷帕霉素(mTOR)抑制剂的机制靶点，实体瘤的治疗，淋巴瘤的治疗
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.3.3509749
F. Bertoni, C. Tarantelli
{"title":"Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma","authors":"F. Bertoni, C. Tarantelli","doi":"10.1358/dof.2023.48.3.3509749","DOIUrl":"https://doi.org/10.1358/dof.2023.48.3.3509749","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66447009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pozelimab/cemdisiran. Complement protein C5 inhibitor, Treatment of complement-mediated diseases Pozelimab / cemdisiran。补体蛋白C5抑制剂，补体介导疾病的治疗
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.2.3474537
M. Griffin
{"title":"Pozelimab/cemdisiran. Complement protein C5 inhibitor, Treatment of complement-mediated diseases","authors":"M. Griffin","doi":"10.1358/dof.2023.48.2.3474537","DOIUrl":"https://doi.org/10.1358/dof.2023.48.2.3474537","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pipeline on the Move - February 2023 管道在移动- 2023年2月
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.2.3556146
L. Fernández Bertolín
{"title":"Pipeline on the Move - February 2023","authors":"L. Fernández Bertolín","doi":"10.1358/dof.2023.48.2.3556146","DOIUrl":"https://doi.org/10.1358/dof.2023.48.2.3556146","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66447070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Society of Hematology - 64th Annual Meeting and Exposition. New Orleans - December 10-13, 2022 美国血液学学会第64届年会暨博览会。新奥尔良——2022年12月10日至13日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.3.3560011
G. Walker, M. Sridevi
{"title":"American Society of Hematology - 64th Annual Meeting and Exposition. New Orleans - December 10-13, 2022","authors":"G. Walker, M. Sridevi","doi":"10.1358/dof.2023.48.3.3560011","DOIUrl":"https://doi.org/10.1358/dof.2023.48.3.3560011","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66447152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic targets for giant cell arteritis 巨细胞动脉炎的治疗靶点
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2023-01-01 DOI: 10.1358/dof.2023.48.2.3556148
L. Sorbera, C. Dulsat, A. Graul
{"title":"Therapeutic targets for giant cell arteritis","authors":"L. Sorbera, C. Dulsat, A. Graul","doi":"10.1358/dof.2023.48.2.3556148","DOIUrl":"https://doi.org/10.1358/dof.2023.48.2.3556148","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66447175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信